©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Medipharm Labs
MediPharm Reports Q2 2025 Financial Results
TORONTO -- MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids, reported its financial results for the three and six months ended June 30,...
Rubicon Organics Pays MediPharm Labs $4.5M for Operational Cultivation Facility
VANCOUVER, British Columbia – Rubicon Organics Inc. acquired an operational, purpose-built 47,500-sq.-ft. indoor cultivation facility in Hope, British Columbia, from MediPharm Labs for $4.5...
Kensana Health Buys MediPharm’s Napanee Facility for $5.5M
TORONTO - MediPharm Labs Corp. and Kensana Health Inc. have entered into a share purchase agreement for the purchase and sale of MediPharm's facility in...
MediPharm Labs Reports Second Quarter Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids reported its financial results for the three and six months ended June 30,...
MediPharm Labs Reports First Quarter Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three months ended March 31, 2024.
Select Highlights
Revenue increased...
MediPharm Labs Reports Third Quarter Results
TORONTO - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ), a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the...
MediPharm Labs Converts All Tilray Shares to Cash
TORONTO - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) a company specialized in precision-based cannabinoids, is pleased to announce it has now received...
MediPharm Labs Settles an Outstanding Claim for $9M
TORONTO -
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a company specialized in precision-based cannabinoids, is pleased...
MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million
TORONTO -
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is...
MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner...
TORONTO - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is...